These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17714061)

  • 21. Choosing therapy for childhood asthma.
    Lemanske RF
    Paediatr Drugs; 2001; 3(12):915-25. PubMed ID: 11772152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the effects of an inhaled corticosteroid and long-acting beta-agonist on therapeutic targets.
    Settipane RA;
    Allergy Asthma Proc; 2003; 24(2):85-9. PubMed ID: 12776440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
    Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
    Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D; Salvio F; Hicks G
    Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.
    Thomson NC
    Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of preventive treatment with long-acting beta(2)-adrenergic agonists and inhaled corticosteroids on the morbidity and mortality of severe asthma exacerbations in 1543 patients].
    Plaza V; Bellido-Casado J; Rodrigo GJ; Solarte I; Rodríguez-Trigo G; Sepúlveda R; Neffen H; Perpiñá M
    Arch Bronconeumol; 2009 Nov; 45(11):545-9. PubMed ID: 19651467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
    J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?
    Currie GP; Lee DK; Srivastava P
    Chest; 2005 Oct; 128(4):2954-62. PubMed ID: 16236972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for asthma.
    Treat Guidel Med Lett; 2005 May; 3(33):33-8. PubMed ID: 15821635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.
    Chantaphakul H; Ruxrungtham K
    Expert Opin Pharmacother; 2016; 17(5):631-42. PubMed ID: 26799114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
    Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
    S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.